Author:
Pencolé Lucile,Lê Minh P.,Bouchet-Crivat Florian,Duro Dominique,Peytavin Gilles,Mandelbrot Laurent
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Infectious Diseases,Immunology,Immunology and Allergy
Reference40 articles.
1. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception;Mandelbrot;Clin Infect Dis,2015
2. In-utero ART exposure and the need for pharmacovigilance;Mofenson;Lancet Glob Health,2018
3. Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: patient perspectives from the ECLAIR trial;Murray;HIV Clin Trials,2018
4. Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, noninferiority trial;Margolis;Lancet Lond Engl,2017
5. Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial;Margolis;Lancet Infect Dis,2015
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献